Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who wrote (14569)	2/11/1998 5:48:00 PM
From: Henry Niman	Read Replies (2) of 32384

LGND just put a press release on breast cancer (pre-clinical using a rat model) showing that it is more effective (complete regression in 72% of treated animals) than Tamoxifen (complete regression in 33% of treated animals) and it synergizes with Tamoxifen. They are re-evaluating their Phase II trials and looking to start some human breast cancer trials with Targretin.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next